References
- Avrahami D., Shai Y.: A new group of antifungal and antimicrobial lipopeptides derived from non-membrane active peptides conjugated to palmitic acid. J. Biol. Chem. 279, 12277–12285 (2004)
- Avrahami D., Shai Y.: Bestowing antifungal and antibacterial activities by lipophilic acid conjugation to D,L-amino acidcontaining antimicrobial peptides: A plausible mode of action. Biochemistry-US, 42, 14946–14956 (2003)
- Avrahami D., Shai Y.: Conjugation of a magainin analogue with lipophilic acids controls hydrophobicity, solution assembly and cell selectivity. Biochemistry-US, 41, 2254–2263 (2002)
- Azmi F, Elliot A.G., Marasini N., Ramu S., Ziora Z., Kavanagh A.M., Blaskovich M.A.T., Cooper M.A., Skwarczynski M., Toth I.: Short cationic lipopeptides as effective antibacterial agents: Design, physicochemical properties and biological evaluation. Bioorgan. Med. Chem. 24, 2235–2241 (2016)
- Bahar A.A., Ren D.: Antimicrobial Peptides. Pharmaceuticals, 6, 1543–1575 (2013)
- Bai Y., Liu S.P., Jiang P., Zhou L., Li J., Tang C., Verma C., Mu Y.G., Beuerman R.W., Pervushin K.: Structure-dependent charge density as a determinant of antimicrobial activity of peptide analogues of defensin. Biochemistry-US, 48, 7229–7239 (2009)
- Bai Y., Liu S.P., Li J.G., Lakshminarayan R., Sarawathi P., Tang C., Ho D.C., Verma C., Beuerman R.W., Pervushin K.: Progressive Structuring of a Branched Antimicrobial Peptide on the Path to the Inner Membrane Target. J. Biol. Chem. 287, 26606–26617 (2012)
- Barańska-Rybak W., Pikuła M., Dawgul M., Kamysz W., Trzonkowski P., Roszkiewicz J.: Safety profile of antimicrobial peptides: Camel, Citropin, Protegrin, Temporin A and lipopetide on HaCaT keratinocytes. Acta. Pol. Pharm. 70, 795–801 (2013)
- Barchiesi F., Giacometti A., Cirioni O., Arzeni D., Silvestri C., Kamysz W., Abbruzzetti A., Riva A., Kamysz E., Scalise G.: In vitro activity of the synthetic lipopeptide PAL-Lys-Lys-NH(2) alone and in combination with antifungal agents against clinical isolates of Cryptococcus neoformans. Peptides, 28, 1509–1513 (2007)
- Bhunia A., Mohanram H., Domadia P.N., Torres J., Bhattacharjya S.: Designed beta-Boomerang Antiendotoxic and Antimicrobial peptides. Structures and activities in lipopolysaccharide, J. Biol. Chem. 284, 21991–22004 (2009)
- Błażewicz I., Jaśkiewicz M., Piechowicz L., Kamysz W., Nowicki R., Barańska-Rybak W.: Rola peptydów przeciwdrobnoustrojowych w wybranych dermatozach. Przegl. Dermatol. 103, 227–232 (2016)
- Catiau L., Traisnel J., Delval-Dubois V., Chihib N.E., Guillochon D., Nedjar-Arroume N.: Minimal antimicrobial peptidic sequence from hemoglobin alpha-chain: KYR. Peptides, 32, 633–638 (2011)
- Cirioni O., Scalise G. i wsp.: The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection. Peptides, 28, 1299–1303 (2007)
- Citterio L., Franzyk H., Palarasah Y., Andersen T.E., Mateiu R.V., Gram L.: Improved in vitro evaluation of novel antimicrobials: potential synergy between human plasma and antibacterial peptidomimetics, AMPs and antibiotics against human pathogenic bacteria, Res. Microbiol. 167, 72–82 (2016)
- Cochrane A.S, Findlay B., Bakhtiary A., Acedo J.Z., Rodriguez-Lopez E.M, Mercier P., Vederas J.C.: Antimicrobial lipopeptide tridecaptin A1 selectivelybinds to Gram-negative lipid II. P. Natl. Acad. Sci. USA, 113, 11561–11566 (2016)
- Dawgul M., Barańska-Rybak W., Greber K., Guzik Ł., Nowicki R., Łukasiak J., Kamysz W.: Aktywność przeciwbakteryjna krótkich lipopeptydów wobec klinicznych szczepów Staphylococcus aureus. Alergia Astma Immunologia, 16, 31–36 (2001)
- Dawgul M., Barańska-Rybak W., Bielińska S., Nowicki R., Kamysz W.: Wpływ peptydów przeciwdrobnoustrojowych na biofilm Candida. Alergia Astma Immunologia, 15, 220–225 (2010)
- Dawgul M., Maciejewska M., Jaskiewicz M., Karafova A., Kamysz W.: Antimicrobial peptides as potential tool to fight bacterial biofilm, Acta. Pol. Pharm. 71, 39–47 (2014)
- Eckhard L.H., Houri-Haddad Y., Sol A., Zeharia R., Shai Y., Beyth S., Domb A.J., Bachrach G., Beyth N.: Sustained release of Antibacterial Lipopeptides from Biodegradable Polymers against Pral Pathogens, Plos One, 11, e0162537 (2016)
- Fenyou She, Nimmagadda A., Teng P., Su M., Zuo X.B., Cai J.F.: Helical 1:1 alpha/Sulfono-gamma-AA Heterogeneous Peptides with Antimicrobial Activity, Biomacromolecules, 17, 1854–1859 (2016)
- Ghosh C., Konai M.M., Sarkar P., Samaddar S., Haldar J.: Design simple lapidates lysines: bifurcation imparts selective antimibrobial activity. Chem. Med. Chem., 11, 2367–2371 (2016)
- Giuliani A., Rinaldi A.C.: Beyond natural antimicrobial peptides: multimeric peptides and other peptidomimetic approaches. Cell. Mol. Life Sci. 68, 2255–2266 (2011)
- Goldberg K. Sarig H., Zakoon F., Espand R.F., Espand R.M., Mor A.: Sensitization of Gram-negative bacteria by targeting the membrane potential. Faseb J. 27, 3818–3826 (2013)
- Greber K.E., Dawgul M., Kamysz W., Sawicki W.: Cationic Net Charge and Counter Ion Type as Antimicrobial Activity Determinant Factors of Short Lipopeptides. Front. Microbiol. Doi: 10.3389/fmicb.2017.00123 (2017)
- Greber K.E., Ciura K., Belka M., Kawczak P., Nowakowska J., Baczek T., Sawicki W.: Characterization of antimicrobial and hemolytic properties of short synthetic cationic lipopeptides based on QSAR/QSTR approach, Amino acids, DOI: 10.1007/s00726-017-2530-2 (2017)
- Horn J.N., Sengillo J.D., Lin D.J., Romo T.D., Grossfield A.: Characterization of a potent antimicrobial lipopeptide via coarse-grained molecular dynamics, BBA.-Biomembranes. 1818, 212–218 (2012)
- Hu Y.G., Amin M.N., Padhee S., Wang R.S.E., Qiao Q., Bai G., Li Y.Q., Mathew A., Cao C.H., Cai J.F.: Lipidated peptidomimetics with improved antimicrobial activity. ACS. Med. Chem. Lett.3, 683–686 (2012)
- Hu Y.G., Li X.L., Sebti S.M., Chen J.D., Cai J.F.: Design and synthesis of AApeptides: a new class of peptide mimics. Bioorg. Med. Chem. Lett. 21, 1469–1471 (2011)
- Iyer V.: A review of stapled peptides and small molecules to inhibit protein-protein interactions in cancer. Curr. Med. Chem. 23, 3025–3043 (2016)
- The APD: The Antimicrobial Peptide Database, http://aps.unmc. edu/AP/main.php (24.02.2018)
- Jammal J., Zakoon F., Kaneti G., Goldberg K., Mor A.: Sentsitization of Gram-negative bacteria to rifampin and OAK combinations. Sci. Rep.-UK, DOI: 10.1038/srep09216
- Jammal J., Zaknoon F., Kaneti G., Herhkovits A.S., Mor A.: Sensitization of Gram-negative Bacilli to Host Antimicrobial Proteins, JPN. J. Infect. Dis. 215, 1599–1607 (2017)
- Janiszewska J. Naturalne peptydy przeciwdrobnoustrojowe w zastosowaniach biomedycznych. Polimery, 59, 699–707 (2014)
- Janiszewska J., Sowinska M., Rajnisz A., Solecka J., Lacka I., Milewski S., Urbanczyk-Lipkowska Z.: Novel dendrimeric lipopeptides with antifungal activity, Bioorg. Med. Chem. Lett. 22, 1388–1393 (2012)
- Jansen R.O., Sandberg-Schaal A., Frimodt-Moller N., Nielsen H.M., Franzyk H.: End group modification: Efficient tool for improving activity of antimicrobial peptide analogues towards Gram-positive bacteria, Eur. J. Pharm. Biopharm. 95, 40–46 (2015)
- Jaśkiewicz M., Neubauer D., Kamysz W.: Comparative Study on Antistaphylococcal Activity of Lipopeptides in Various Culture Media. Antibiotics, DOI:10.3390/antibiotics6030015 (2017)
- Jenner Z.B., Crittenden C.M., Gonzales M., Brodbelt J.S., Bruns K.A.: Hydrocarbon-stapled lipopeptides exhibit selective antimicrobial activity, Biopolymers, 108, e23006 (2017)
- Jerala R.: Synthetic lipopeptides: a novel class of anti-infectives, Expert. Opin. Inv. Drug. 16, 1159–1169 (2007)
- Kamysz E., Barchiesi F. i wsp.: In vitro activity of the lipopeptide PAL-Lys-Lys-NH2, alone and in combination with antifungal agents, against clinical isolates of Candida spp. Peptides, 32, 99–103 (2011)
- Kamysz E., Sikorska E., Dawgul M., Tyszkowski R., Kamysz W.: Influence of dimerization of lipopeptide Laur-Orn-Orn-Cys-NH2 and N-terminal peptide of human lactoferricin on biological activity. Int. J. Pept. Res. Ther. 21, 39–46 (2015)
- Kamysz W.: Projektowanie, synteza i badania peptydów przeciwdrobnoustrojowych. Akademia Medyczna. Gdańsk, 2007
- Kaur P., Li Y.Q., Cai F.J., Song L.K.: Selective membrane disruption mechanism of an antibacterial gamma-AApeptide defined by EPR spectroscopy. Biophys. J. 110, 1789–1799 (2016)
- Koh J.J., Lin S.M., Beuerman R.W., Liu S.P.: Recent advances in synthetic lipopeptides as anti-microbial agents: design and synthetic approaches, Amino acids, 49, 1653–1677 (2017)
- Kozińska A., Sitkiewicz I.:. "Nowe” i "Stare” antybiotyki – mechanizmy działania i strategie poszukiwania leków przeciwbakteryjnych. Kosmos, 66, 109–124 (2017)
- Lakshminarayanan R., Beuerman R.W. I wsp.: Branched peptide, B2088, disrupts the supramolecular organization of lipopolysaccharides and sensitizes the Gram-negative bacteria, Sci. Rep.-UK, 6, DOI: 10.1038/srep25905 (2016)
- Laverty G., McLaughlin M., Shaw C., Gorman S.P., Gilmore B.F.: Antimicrobial Activity of Short, Synthetic Cationic Lipopeptides, Chem. Biol. Drug. Des. 75, 563–569 (2010)
- Li J., Koh J.J, Liu S., Lakshminarayanan R., Verma C.S, Beuerman R.W.: Membrane Active Antimicrobial Peptides: Translating Mechanistic Insights to Design. Front. Neurosci. Doi: 10.3389/fnins.2017.00073 (2017)
- Li J.G., Liu S.P., Lakshminarayanan R., Bai Y., Pervushin K., Verma C., Beuerman R.W.: Molecular simulations suggest how a branched antimicrobial peptide perturbs a bacterial membrane and enhances permeability, BBA. – Biomembranes, 1828, 1112–1121 (2013)
- Lin D.J., Grossfield A.: Thermodynamics of antimicrobial lipopeptide binding to membranes: origins of affinity and selectivity. Biophys. J. 107, 1862–1872 (2014)
- Lohan S., Cameotra S.S., Bisht G.S.: Systematic study of non-natural short cationic lipopeptides as novel broad-spectrum antimicrobial agents. Chem. Biol. Drug. Des. 82, 557–566 (2013)
- Majerle A., Kidric J. Jerala R.: Enhancement of antibacterial and lipopolysaccharide binding activities of a human lactoferrin peptide fragment by the addition of acyl chain. J. Antimicrob. Chemoth. 51, 1159–1165 (2003)
- Mak P., Pohl J., Dubin A., Reed M.S., Bowers S.E., Fallon M.T., Shafer W.M.: The increased bactericidal activity of a fatty acid-modified synthetic antimicrobial peptide of human cathepsin G correlates with its enhanced capacity to interact with model membranes. Int. J. Antimicrob. Ag. 21, 13–19 (2003)
- Makovitzky A., Avrahami D., Shai Y.: Ultrashort antibacterial and antifungal lipopeptides. P. Natl. Acad. Sci. USA, 103, 15997–16002 (2006)
- Makovitzky A., Baram J. Shai Y.: Antimicrobial lipopolypeptides composed of palmitoyl di- and tricationic peptides: in vitro and in vivo activities, self-assembly to nanostructures and plausible mode of action. Biochemistry-US, 47, 10630–10636 (2008)
- Malina A., Shai Y.: Conjugation of fatty acids with different lengths modulates the antibacterial and antifungal activity of cationic biologically inactive peptide, Biochem. J. 390, 695–702 (2005)
- Mangoni M.L., Shai Y.: Short native antimicrobial peptides and engineered ultrashort lipopeptides: similarities and differences in cell specificities and modes of action, Cell Mol. Life Sci. 68, 2267–2280 (2011)
- Migon D., Neubauer D., Kamysz W.: Hydrocarbon Stapled Antimicrobial Peptides. Protein J. DOI: 10.1007/s10930-018-9755-0 (2018)
- Min K.R., Galvis A., Williams B., Rayala R., Cudic P., Ajdic D.: Antibacterial and Antibiofilm Activities of a Novel Synthetic Cyclic Lipopeptide against Cariogenic Streptococcus mutans UA159. Antimicrob. Agents. Chemother. DOI: 10.1128/AAC.00776-17 (2017)
- Mirski T., Gryko R., Bartoszcze M., Bielwaska-Drózd A., Tyszkiewicz W.: Peptydy przeciwdrobnoustrojowe – nowe możliwości zwalczania infekcji u ludzi i zwierząt. Medycyna Wet. 67, 517–521 (2011)
- Mishra B., Lushnikova T., Wang G.S.: Small lipopeptides possess anti-biofilm capability comparable to daptomycin and vancomycin. RSC. Adv. 5, 59758–59769 (2015)
- Mizerska-Dudka M., Andrejko M., Kondefer-Szerszeń M.. Przeciwirusowe peptydy kationowe człowieka i owadów. Post. Mikrobiol. 50, 209–216 (2011)
- Mohanram H., Bhattacharjya S.: ‘Lollipop’-shaped helical structure of a hybrid antimicrobial peptide of temporin B – lipopolysaccharide binding motif and mapping cationic residues in antibacterial activity, BBA. – Gen. Subjects. 1860, 1362–1372 (2016)
- Mohanram H., Bhattacharjya S.: beta-Boomerang Antimicrobial and antiendotoxic peptides: lipidation and disulfide bond effects on activity and structure. Pharmaceuticals (Basel, Switzerland),7, 482–501 (2014)
- Nasompag S., Dechsiri P., Hongsing N., Phonimdaeng P., Daduang S., Klaynongsruang S., Camesano T.A., Patramanon R.: Effect of acyl chain length on therapeutic activity and mode of action of the C-X-KYR-NH2 antimicrobial lipopeptide. BBA. – Biomembranes, 1848, 2351–2364 (2015)
- Nedjar-Arroume N., Dubois-Delval V., Adje E.Y., Traisnel J., Krier F., Mary P., Kouach M., Briand G., Guillochon D.: Bovine hemoglobin: an attractive source of antibacterial peptides. Peptides, 29, 969–977 (2008)
- Niu Y.H., Cai J.F I wsp.: Lipo-gamma-AApeptides as a new class of potent and broad-spectrum antimicrobial agents. J. Med. Chem. 55, 4003–4009 (2012)
- Omardien S., Brul S., Zaat S.A.J.: Antimicrobial Activity of Cationic Antimicrobial Peptides against Gram-Positives: Current Progress Made in Understanding the Mode of Action and the Response of Bacteria. Front. Cell. Dev. Biol. Doi: 10.3389/fcell.2016.00111 (2016)
- Oren Z., Lerman J.C., Gudmundsson G.H., Agerberth B., Shai Y.: Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. Biochem. J. 341, 501–513 (1999)
- Padhee S., Li Y.Q., Cai J.F.: Activity of lipo-cyclic gamma-AApeptides against biofilms of Staphyloccocus epidermidisand Pseudomonas aeruginosa, Bioorg. Med. Chem. Lett. 25, 2565–2569 (2015)
- Papo N., Oren Z., Pag U., Sahl H.G., Shai Y.: The consequence of sequence alternation of an amphipathic alpha-helical antimicrobial peptide and its diastereomers. J. Biol. Chem. 277, 33913–33921 (2002)
- Radzishevsky I.S., Rotem S., Bourdetsky D., Navon-Venezia S., Carmeli Y., Mor A.: Impoved antimicrobial peptides based on acyl-lysine oligomers. Nat. Biotechnol. 25, 657–659 (2007)
- Sang P., Shi Y., Teng P., Cao A.N., Xu H., Li Q., Cai J.F.: Antimicrobial AApeptides, Curr. Top. Med. Chem. 17, 1266–1279 (2017)
- Sarig H. Livne L., Held-Kutnetsov V., Zakoon F., Ivankin A., Gidalevitz D., Mor A.: A miniature mimic of host defense peptides with systematic antibacterial efficacy. Faseb J. 24, 1904–1913 (2010)
- Shai Y., Makovitzky A., Avrahami D.: Host defense peptides and lipopeptides: mode of action and potential candidates for the treatment of bacterial and fungal infections. Curr. Protein Pept. Sci. 7, 479–486 (2006)
- Sikorska E., Dawgul M., Greber K., Ilowska E., Pogorzelska A., Kamysz W.: Self-assebly and interactions of short antimicrobial lipopeptides with membrane lipids: ITC, FTIR and molecular dynamics studies. BBA.-Biomembranes, 1838, 2625–2634 (2014)
- Straus S.K., Hancock R.E.W.: Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: comparison with cationic antimicrobial peptides and lipopeptides. BBA.-Biomembranes, 1758, 1215–1223 (2006)
- Teng P., Cai J.F. I wsp.: Small Antimicrobial Agents Based on Acylated Reduced Amide Scaffold, J. Med. Chem. 59, 7877–7887 (2016)
- Wang G.: Improved Methods for Classification, Prediction and Design of Antimicrobial Peptides. Method. Mol. Cell Biol. 1268, 43–66 (2015)
- Wiesner J., Vilcinskas A.: Antimicrobial peptides: the ancient arm of the human immune system. Virulence, 1, 440–464 (2010)
- Wódz K., Brzezińska-Błaszczyk E., Katelicydyny – endogenne peptydy przeciwdrobnoustrojowe. Postępy Biochemii, 61, 93–101 (2015)
- Zdybicka-Barabas A., Stączek S., Cytryńska M.: Różnorodność peptydów przeciwdrobnoustrojowych bezkręgowców. Kosmos, 66, 563–574 (2017)
- Zhang L.J, Gallo R.L.: Antimicrobial peptides. Curr. Biol. 26, 14–19 (2016)
- Żyłowska M., Wyszyńska A., Jagusztyn-Krynicka E.K.: Defensysny – peptydy o aktywności przeciwbakteryjnej. Post. Mikrobiol. 50, 223–234 (2011)